The global CRO where clinical trials run on time
Finding a CRO to deliver your trials on time and on budget isn’t easy. Choose the CRO you can trust.
Be ahead of your time.
Our mission is to be the best CRO in the world as measured by our employees, clients, investigators, and vendors.
Our teams work tirelessly to ensure that we deliver on time and on budget. You will always know what’s going on with your study when you work with PSI. That means not losing control over study timelines and budgets.
Therapeutic areas
Oncology
Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Ovarian Cancer and other Oncology indications.
Hematology
Multiple Myeloma, Lymphomas, Leukemias and other oncohematological indications.
Rare Diseases
Hemophilia A & B, Von Willebrand Disease, Thrombocytopenia, Polycythemia Vera, Paroxysmal Nocturnal Hemoglobinuria (PNH).
The PSI Advantage
PSI CRO has received CRO Leadership Awards in five categories, including Compatibility, Expertise, Quality, Reliability, and Capabilities across two respondent groups (Overall and Small Pharma). The CRO Leadership Awards are presented by Life Sciences Leader ased on research conducted by ISR reports. The awards recognize CROs that are voted by sponsors to meet or exceed expectations.
PSI On Point
Meet us on Zoom
Social distancing is important, and we’re all doing our part to limit the spread of COVID-19. Instead of meeting at events and conferences, click here to contact us today and schedule time to meet virtually.
PSI has been exceedingly professional and is respected by our site as a great collaborator.
Anthony W. Tolcher, MD, FRCP, FACP